Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2011
06/21/2011CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon
06/21/2011CA2340328C Stable hypoxia inducible factor-1 alpha and method of use
06/21/2011CA2316739C Preparation of cells for production of biologicals
06/21/2011CA2303460C Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
06/21/2011CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
06/21/2011CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
06/21/2011CA2280791C Immunological detection of prions
06/21/2011CA2172392C Methods of inhibiting phagocytosis
06/21/2011CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders
06/16/2011WO2011072292A2 Phase changing formulations of rna and rna derivatives
06/16/2011WO2011072276A2 Cell lines from the black witch moth ascalapha odorata
06/16/2011WO2011072247A2 Pathogen restriction factors
06/16/2011WO2011072119A2 Stem-cell material and method of use
06/16/2011WO2011072088A2 Improved methods of cell culture for adoptive cell therapy
06/16/2011WO2011071936A2 Compositions and methods for reprogramming eukaryotic cells
06/16/2011WO2011071931A2 Rna preparations comprising purified modified rna for reprogramming cells
06/16/2011WO2011071297A2 Composition for analyzing the pluripotency of pig stem cells
06/16/2011WO2011071147A1 Novel expression vector, and process for production of protein using the vector
06/16/2011WO2011071118A1 Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin
06/16/2011WO2011071099A1 Anticancer anti-mortalin peptide antibodies
06/16/2011WO2011071085A1 Method for producing cells induced to differentiate from pluripotent stem cells
06/16/2011WO2011071058A1 Preparation method for optically active 2-hydroxycycloalkane carboxylic acid ester
06/16/2011WO2011070405A1 An expression vector carrying scaffold/matrix attachment region(s)
06/16/2011WO2011070001A1 Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
06/16/2011WO2011036637A3 Cell culture medium
06/16/2011WO2011019822A3 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
06/16/2011WO2011019401A3 Cell coated implantable device
06/16/2011WO2011017143A3 Compositions and methods of preparing alloreactive cytotoxic t cells
06/16/2011WO2011011388A3 Neuregulin induced regeneraton of heart muscle muscle
06/16/2011WO2011008986A3 A method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
06/16/2011US20110145953 Marker mapping and resistance gene associations in soybean
06/16/2011US20110145946 Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
06/16/2011US20110145944 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles
06/16/2011US20110145940 Tal effector-mediated dna modification
06/16/2011US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells
06/16/2011US20110144313 Membrane fusion proteins derived from reovirus
06/16/2011US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products
06/16/2011US20110144192 Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria
06/16/2011US20110144185 Rna antagonists targeting hsp27
06/16/2011US20110144131 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines
06/16/2011US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters
06/16/2011US20110144113 Triazolotriazines as kinase inhibitors
06/16/2011US20110144107 Compounds and compositions useful for the treatment of malaria
06/16/2011US20110144096 Treating various disorders using trkb agonists
06/16/2011US20110144074 Caspase inhibitors and uses thereof
06/16/2011US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors
06/16/2011US20110144064 Inhibitors of Kynurenine Aminotransferase and Uses Therefor
06/16/2011US20110144043 Stat modulators
06/16/2011US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use
06/16/2011US20110144031 Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same
06/16/2011US20110144029 Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases
06/16/2011US20110144028 Modulating cellular electrophysiology
06/16/2011US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure
06/16/2011US20110144023 Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells
06/16/2011US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle
06/16/2011US20110143954 Gamma-secretase substrate and methods of use
06/16/2011US20110143443 Isolsted Monoclonal - Associated Protein Tau and Kit
06/16/2011US20110143441 Methods of Reprogramming Animal Somatic Cells
06/16/2011US20110143440 Mutations caused by activation-induced cytidine deaminase
06/16/2011US20110143439 Method for manufacturing cell culture substrate
06/16/2011US20110143438 Process for Decellularizing Soft-Tissue Engineered Medical Implants, and Decellularized Soft-Tissue Medical Implants Produced
06/16/2011US20110143437 Method for using directing cells for specific stem/progenitor cell activation and differentiation
06/16/2011US20110143436 Compositions and methods for reprogramming eukaryotic cells
06/16/2011US20110143435 Polymeric carrier
06/16/2011US20110143434 Diblock copolymers and polynucleotide complexes thereof for delivery into cells
06/16/2011US20110143433 Microcarriers for Stem Cell Culture
06/16/2011US20110143432 Use of extract of selenium-enriched yeast (se-ye) in mammalian cell culture media formulations
06/16/2011US20110143431 Method Of Preparing An Undifferentiated Cell
06/16/2011US20110143430 Hematopoietic stem cell identification and isolation
06/16/2011US20110143429 Tissue engineered blood vessels
06/16/2011US20110143428 Anti-vegf-c antibodies and methods using same
06/16/2011US20110143427 High-throughput methods and systems for processing biological materials
06/16/2011US20110143415 Reprogramming normal and cancerous human cell lines into human induced poluripotent stem cells by co-electroporation with living xenopus laevis frog oocytes
06/16/2011US20110143397 Rna preparations comprising purified modified rna for reprogramming cells
06/16/2011US20110143387 Highly water-soluble, cationic luminescent labels
06/16/2011US20110143385 Plasma membrane vesicles and methods of making and using same
06/16/2011US20110143373 Method of evaluating the integrity of the plasma membrane of cells by detecting glycans found only intracellularly
06/16/2011US20110143370 Nucleic Acids Encoding a Mammalian Raptor Polypeptide and Uses Therefor
06/16/2011US20110143367 Antibodies against april as biomarkers for early prognosis of lymphoma patients
06/16/2011US20110143340 Non-invasive isolation of fetal nucleic acid
06/16/2011US20110143331 Methods and Compositions for the Preservation of Cells and Tissues
06/16/2011US20110142951 Micelles for intracellular delivery of therapeutic agents
06/16/2011US20110142941 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof
06/16/2011US20110142935 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods
06/16/2011US20110142911 HIV epitopes and pharmaceutical composition containing same
06/16/2011US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
06/16/2011US20110142887 Methods and compositions for liquidation of tumors
06/16/2011US20110142880 Lentivirus-based immunogenic vectors
06/16/2011US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
06/16/2011US20110142874 Compositions, Methods, and Kits for Eliciting an Immune Response
06/16/2011US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection
06/16/2011US20110142870 Bacillus anthracis antigens, vaccine compositions, and related methods
06/16/2011US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine
06/16/2011US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
06/16/2011US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
06/16/2011US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
06/16/2011US20110142854 Compositions and methods for inhibition of retroviruses
06/16/2011US20110142851 IL6 Immunotherapeutics
06/16/2011US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41
06/16/2011US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 1827